| Date Filed | Type | Description |
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2020 |
4
| COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Sold 52,100 shares
@ $0.1834, valued at
$9.6k
Sold 25,000 shares
@ $0.1913, valued at
$4.8k
|
|
| 08/06/2020 |
4
| COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 506,292 shares
@ $0.2, valued at
$101.3k
|
|
| 08/06/2020 |
3
| COUCHMAN JONATHAN (10% Owner) has filed a Form 3 on ENZON PHARMACEUTICALS, INC. |
| 03/31/2020 |
4/A
| COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 19,709 shares
@ $0.135, valued at
$2.7k
Bought 2,678 shares
@ $0.14, valued at
$374.9
Bought 469,551 shares
@ $0.14, valued at
$65.7k
Bought 160,785 shares
@ $0.14, valued at
$22.5k
|
|
| 03/31/2020 |
3
| Myrexis, Inc. (See Footnote 1) has filed a Form 3 on ENZON PHARMACEUTICALS, INC. |
| 07/31/2013 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 07/26/2013 |
10-K/A
| Annual Report for the period ended June 30, 2013 [amend] |
| 07/17/2013 |
10-K
| Annual Report for the period ended June 30, 2013 |
| 05/10/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 04/29/2013 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 04/18/2013 |
8-K
| Quarterly results |
| 03/22/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/11/2013 |
3
| Xstelos Holdings, Inc. (10% Owner) has filed a Form 3 on Myrexis, Inc. |
| 03/11/2013 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements |
| 03/11/2013 |
SC 13D
| Xstelos Holdings, Inc. reports a 20.3% stake in Myrexis, Inc. |
| 03/05/2013 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
| 02/28/2013 |
8-K
| Other Events |
| 02/27/2013 |
SC 13D/A
| ICS OPPORTUNITIES, LTD. reports a 2% stake in Myrexis, Inc. |
| 02/20/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/19/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 02/14/2013 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 6.2% stake in Myrexis, Inc. |
| 02/13/2013 |
SC 13G/A
| Bulldog Investors reports a 9.8% stake in Myrexis, Inc. |
| 02/08/2013 |
10-Q
| Quarterly Report for the period ended December 31, 2012 |
| 01/25/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/21/2012 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 12/21/2012 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 12/14/2012 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 11/13/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/09/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
| 11/09/2012 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 11/05/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/02/2012 |
4
| First Eagle Investment Management, LLC (10% Owner) has filed a Form 4 on Myrexis, Inc.|
Txns:
| Sold 35,000 shares
@ $2.37, valued at
$83k
|
|
| 10/29/2012 |
10-K/A
| Annual Report for the period ended June 30, 2012 [amend] |
|